戻る Agenda
Session 2 Track 2A: Are You Calling Me Transparent? Insights into Clinical Trial Transparency: Layperson Summaries and the Plain Language Initiative
Session Chair(s)
David Meats
Director, Regulatory Services Management
Certara, United States
This session discusses the continuously expanding approach to transparency in pharmaceutical development. We will explore the most current breaking developments in the Clinical Trial Transparency space. In addition, we will cover tips for the development of trial summaries using plain language and what patients and healthcare providers want from these summaries.
Speaker(s)
Speaker
Deborah Collyar
Patient Advocates In Research (PAIR), United States
President
Speaker
Theresa Shalaby, MSN, RN
Certara Synchrogenix, United States
Sr. Regulatory Services Manager